The digital health landscape saw significant activity this week, with OpenLoop acquiring AI-powered communication platform Hey Revia. This strategic move aims to enhance OpenLoop’s virtual care offerings and patient engagement capabilities, reflecting a broader industry trend towards consolidating AI functionalities.
In parallel, Aurenar received FDA breakthrough device designation for its intracranial hemorrhage treatment, signaling potential acceleration in regulatory review for critical medical innovations. Meanwhile, Sharecare has partnered with Amazon Web Services (AWS) to power its AI health navigation tool, AskMD. This collaboration leverages Amazon Bedrock to orchestrate multiple AI models, offering users a unified interface for symptom assessment, insurance navigation, provider search, and care option evaluation.
Further underscoring investment in the sector, Upside, a platform focused on housing stability for healthcare populations, secured $20 million in funding. This investment points to a growing recognition of the impact of social determinants of health on outcomes and costs.
Discussions at the HIMSS AI in Healthcare Forum emphasized the practical challenges and opportunities in AI deployment, including risk management and trust-building. A key takeaway was the critical need for common data standards to facilitate data sharing and scale AI tools effectively across healthcare systems, with data fragmentation identified as a major impediment.
Looking ahead, Aurenar will advance through the FDA’s expedited review process, OpenLoop will integrate Hey Revia’s technology, and Sharecare’s AskMD initiative on Amazon Bedrock will serve as a significant test case for multi-model AI orchestration in consumer health navigation.
About the Author
